Current Challenges and Opportunities in Molecular Diagnosis of Respiratory Viral Co-Infections in Low-Resource Settings: A Nigerian Perspective

Respiratory viral infection continues to be a public health problem of great concern worldwide especially in low resource settings like Nigeria where there are a lot of infrastructural and diagnostic challenges in the health sector. Co-infections with respiratory viruses (e.g., influenza viruses, respiratory syncytial virus (RSV), adenoviruses, and SARS-CoV-2) have become more common and are complicating the diagnosis, monitoring, and clinical management of disease. Rapid and accurate detection of multiple respiratory pathogens has been enhanced with the use of molecular diagnostic technologies, such as reverse transcription polymerase chain reaction (RT-PCR), multiplex PCR assays, and next-generation sequencing. In Nigeria however, their use is limited due to their cost, poor laboratory facilities, insufficient expertise, inadequate surveillance system and policy issues.
This study used a qualitative systematic review design with contextual policy analysis to explore the molecular diagnosis of respiratory viral co-infections challenges and opportunities in Nigeria. The literature reviewed and analysed was themed and focused on the period 2015-2025.
The study identified that although there are barriers to molecular diagnostics that exist, there are also opportunities such as decentralised point-of-care diagnostics, digital health integration, local production of diagnostic materials, training of the workforce, and investment in post-COVID-19 diagnostics that provide strategic pathways to build molecular diagnostic capacity and enhance healthcare system preparedness for infectious diseases in low-resource settings.

Molecular Diagnostics, Respiratory Viral Co-Infections

1. Akanbi, M. O., and Ukoli, C. O. (2009). The burden of respiratory disease in Nigeria. African Journal of Respiratory Medicine. https://www.africanjournalofrespiratorymedicine.com/articles/the-burden-of-respiratory-disease-in-nigeria.pdf [Google Scholar] [Crossref]

2. Alzahrani, A. J. (2026). Molecular point-of-care testing for respiratory infections: A comprehensive literature review (2006–2026). Diagnostics, 16(6), 930. https://www.mdpi.com/2075-4418/16/6/930 [Google Scholar] [Crossref]

3. Asner, S. A., et al. (2014). Clinical disease severity of respiratory viral co-infection versus single viral infection: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0099392 [Google Scholar] [Crossref]

4. Babawale, P. I., and Guerrero-Plata, A. (2024). Respiratory viral coinfections: Insights into epidemiology, immune response, pathology and clinical outcomes. Pathogens, 13(4), 316. https://www.mdpi.com/2076-0817/13/4/316 [Google Scholar] [Crossref]

5. Bastug, K., et al. (2025). Utilization of Oxford Nanopore Technology for human infectious diseases detection and surveillance in Africa: A scoping review. Access Microbiology. https://www.microbiologyresearch.org/content/journal/acmi/10.1099/acmi.0.001020 [Google Scholar] [Crossref]

6. Chen, H., et al. (2023). Towards point of care CRISPR-based diagnostics. Frontiers in Molecular Biosciences. https://pmc.ncbi.nlm.nih.gov/articles/PMC9967495/ [Google Scholar] [Crossref]

7. Clark, T. W., et al. (2023). Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: Results of a systematic review and meta-analysis. Journal of Infection. https://doi.org/10.1016/j.jinf.2023.03.005 [Google Scholar] [Crossref]

8. Das, P. K., et al. (2025). CRISPR-Cas diagnostics (CRISPR-Dx) of viral pathogens. TrAC Trends in Analytical Chemistry. https://www.sciencedirect.com/science/article/pii/S0165993625004583 [Google Scholar] [Crossref]

9. Demboux Lyelet, J. E., et al. (2025). Viral and bacterial etiology of common respiratory infections in children in sub-Saharan Africa: A systematic review. Children, 12(9), 1212. https://www.mdpi.com/2227-9067/12/9/1212 [Google Scholar] [Crossref]

10. Deol, P., et al. (2025). Respiratory viral coinfections: Interactions, mechanisms and consequences. Nature Reviews Microbiology. https://pubmed.ncbi.nlm.nih.gov/40835977/ [Google Scholar] [Crossref]

11. Dhaini, L., et al. (2024). Recommendations on rapid diagnostic point-of-care molecular tests for respiratory infections in the United Arab Emirates. The Open Respiratory Medicine Journal. https://openrespiratorymedicinejournal.com/VOLUME/18/ELOCATOR/e18743064319029/FULLTEXT/ [Google Scholar] [Crossref]

12. Emperador, D. M., et al. (2020). An open-source molecular diagnostic platform approach for decentralized testing in low-resource settings. African Journal of Laboratory Medicine. https://ajlmonline.org/index.php/ajlm/article/view/1017 [Google Scholar] [Crossref]

13. FIND. (2023). Near-point-of-care molecular diagnostics in low- and middle-income countries. https://www.finddx.org/wp-content/uploads/2023/06/20230614_rep_find_market_insights_poc_lmics_FV_EN.pdf [Google Scholar] [Crossref]

14. Huang, H. S., et al. (2018). Multiplex PCR system for the rapid diagnosis of respiratory virus infection: A systematic review and meta-analysis. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2017.11.005 [Google Scholar] [Crossref]

15. Juscamayta-López, E., et al. (2021). A multiplex and colorimetric reverse transcription loop-mediated isothermal amplification assay for simultaneous detection of SARS-CoV-2 and influenza viruses. Frontiers in Cellular and Infection Microbiology. https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2021.653616/full [Google Scholar] [Crossref]

16. Kabantiyok, D., et al. (2022). Human respiratory infections in Nigeria: Influenza and the emergence of SARS-CoV-2 pandemic. Vaccines, 10(9), 1551. https://doi.org/10.3390/vaccines10091551 [Google Scholar] [Crossref]

17. Kaboré, B. W. O., et al. (2025). Viral etiology of acute respiratory infections in Sub-Saharan Africa during the pre-COVID-19 period (2006-2019): A systematic review and meta-analysis. BMC Infectious Diseases. https://pmc.ncbi.nlm.nih.gov/articles/PMC12750592/ [Google Scholar] [Crossref]

18. Koryukov, M. A., et al. (2024). A novel multiplex LAMP assay for the detection of respiratory viruses. Pathogens. https://pmc.ncbi.nlm.nih.gov/articles/PMC11241107/ [Google Scholar] [Crossref]

19. Li, Y., et al. (2022). Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis. The Lancet. https://doi.org/10.1016/S0140-6736(22)00478-0 [Google Scholar] [Crossref]

20. Maduka, C. P., et al. (2023). Review of laboratory diagnostics evolution in Nigeria’s response to COVID-19. https://pdfs.semanticscholar.org/7d3f/477504077e93a5f68c51169891a7e9312873.pdf [Google Scholar] [Crossref]

21. Mahony, J. B. (2008). Detection of respiratory viruses by molecular methods. Clinical Microbiology Reviews. https://doi.org/10.1128/CMR.00037-07 [Google Scholar] [Crossref]

22. Mandelia, Y., et al. (2021). Dynamics and predisposition of respiratory viral co-infections. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2020.08.012 [Google Scholar] [Crossref]

23. Mongan, A. E., et al. (2020). Portable sequencer in the fight against infectious disease. Journal of Human Genetics. https://www.nature.com/articles/s10038-019-0675-4 [Google Scholar] [Crossref]

24. Muoneke, A. P., et al. (2025). Assessing the preparedness of Nigeria’s diagnostic and laboratory infrastructure for Mpox surveillance and response. Discover Public Health, 22, 532. https://doi.org/10.1186/s12982-025-00877-z [Google Scholar] [Crossref]

25. Naidoo, D., et al. (2020). Nigeria’s efforts to strengthen laboratory diagnostics: Why access to reliable and affordable diagnostics is key to building resilient laboratory systems. https://pmc.ncbi.nlm.nih.gov/articles/PMC7479428/ [Google Scholar] [Crossref]

26. Odaibo, G. N., et al. (2013). Incidence and burden of respiratory syncytial virus infection in a community-based cohort of under-five years children in Nigeria. University of Ibadan Repository. https://repository.ui.edu.ng/items/799fc040-51b7-4e1c-aeb1-e660c859e101 [Google Scholar] [Crossref]

27. Okeke, I. N., and Ihekweazu, C. (2021). The importance of molecular diagnostics for infectious diseases in low-resource settings. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-021-00598-5 [Google Scholar] [Crossref]

28. Okoror, E. I., et al. (2025). Respiratory viral infection and HIV viral load and CD4+ cells count of HIV infected children attending selected clinics in Southwest, Nigeria. Discover Viruses, 2, 24. https://doi.org/10.1007/s44370-025-00029-6 [Google Scholar] [Crossref]

29. Osaigbovo, I. I., et al. (2021). Setting up a molecular diagnostic laboratory for SARS-CoV-2 testing: Experience of a single centre in a resource-constrained setting. African Journal of Laboratory Medicine, 10(1), 1326. https://doi.org/10.4102/ajlm.v10i1.1326 [Google Scholar] [Crossref]

30. Tillekeratne, L. G., et al. (2024). Electronic clinical decision support tools: Strategies to improve the management of lower respiratory tract infections in low-resource settings. American Journal of Tropical Medicine and Hygiene. https://www.ajtmh.org/view/journals/tpmd/111/6/article-p1173.xml [Google Scholar] [Crossref]

31. Troeger, C., et al. (2018). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(18)30310-4 [Google Scholar] [Crossref]

32. Vergara-Gómez, A., et al. (2025). Molecular diagnostic techniques in respiratory infections. BRN Reviews. https://brnreviews.com/wp-content/uploads/2026/01/brn_25_11_2_136-157.pdf [Google Scholar] [Crossref]

33. Wang, X., et al. (2024). Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: A systematic review and meta-analysis. The Lancet. https://doi.org/10.1016/S0140-6736(24)00138-7 [Google Scholar] [Crossref]

34. Zhang, S., et al. (2011). Molecular diagnosis of viral respiratory infections. Current Infectious Disease Reports. https://pmc.ncbi.nlm.nih.gov/articles/PMC7088847/ [Google Scholar] [Crossref]

35. Zu, Y., et al. (2025). Molecular point-of-care testing technologies: Current status and future perspectives. https://www.sciencedirect.com/science/article/pii/S2950160125000063 [Google Scholar] [Crossref]

• Tribal Child Nutrition and Health in District of Sundargarh: A Public Health Review of ICDS Intervention
• Knowledge, Attitudes and Practices Towards Prostate Cancer Screening Amongst Men Aged 40-60 Years in The Buea Health District: A Cross-Sectional Study
• Compliance with JCI Protocols: A Focus on Employee Safety
• Influence and Involvement of Teachers in Menstrual Hygiene Management of Female Secondary School Students in Kogi State, Nigeria
• A Critical Evaluation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in Bihar